Bicycle Therapeutics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Bicycle Therapeutics plc (BCYC) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Operating Activities
Net Income-169.03-180.66-112.72-66.82-51.01-30.61
Depreciation & Amortization7.176.553.691.411.280.96
Deferred Income Tax-5.233.31-4.98-1.670.000.00
Stock Based Compensation38.0832.4826.7812.086.510.00
Change in Working Capital-33.4676.660.6739.7326.99-7.05
Change in Accounts Receivable-11.952.48-1.644.54-2.150.00
Change in Accounts Payable3.108.002.561.20-0.660.00
Change in Other Working Capital-24.61-2.771.89-3.124.220.00
Other Operating Activities-2.264.35-4.53-1.204.968.46
Net Cash from Operating Activities-164.72-60.63-86.11-14.79-17.79-28.23
Investing Activities
Capital Expenditures-1.24-2.93-18.99-2.031.201.56
Net Cash from Investing Activities-1.24-2.93-18.99-2.03-1.20-1.56
Financing Activities
Debt Repayment-31.910.000.000.00-0.570.00
Common Stock Issued544.13250.036.69305.7348.1456.96
Other Financing Activities7.530.000.007.56-0.570.00
Net Cash from Financing Activities519.75250.036.69320.7362.8457.11
Summary
Effect of Forex Changes on Cash-0.691.35-1.12-1.210.020.47
Net Change in Cash353.10187.82-99.53302.6943.8527.32
Cash at Beginning of Period526.97339.15438.68135.9992.1263.38
Cash at End of Period880.07526.97339.15438.68135.9991.16
Free Cash Flow-165.96-63.56-105.10-16.82-18.99-29.79
Supplemental Disclosures
Interest Paid1.372.752.792.520.380.00
Income Taxes Paid0.790.562.230.070.120.12